The first IV product shipments cleared by the FDA for temporary importation are set to arrive in the U.S. this weekend, Baxter said on its hurricane update page Thursday. By the end of the year ...

As part of its efforts to mitigate the disruption to the supply of IV solutions after Hurricane Helene temporarily closed its North Cove, N.C., manufacturing plant, Baxter today said that it is now ...

Each flight will carry 100,000 units of Baxter products, such as intravenous and peritoneal fluids, from its international facilities and will be expedited to health care providers across the U.S ...

On Monday, Baxter said it received FDA authorization to extend the use dates of 50+ IV and irrigation codes to provide up to an additional 12 months of expiry. Products now have a 24-month expiry ...

Current and prior year periods now reflect the continuing operations of Baxter's Medical Products & Therapies, Healthcare Systems & Technologies and Pharmaceuticals segment. Now I'd like to turn ...

However, Baxter continues to caution that it still may be mid- to late-November before the products make their way back into the marketplace. The plant experienced significant flooding damage from ...

Oct 17 (Reuters) - Baxter International (BAX.N), opens new tab said on Thursday it will import 18,000 tons of intravenous products from its newly cleared international plants to the U.S. by the ...

(Reuters) - Baxter International said on Thursday it will import 18,000 tons of intravenous products from its newly cleared international plants to the U.S. by the end of the year to mitigate a ...

With the situation growing urgent, Baxter is importing 18,000 tons of essential products to alleviate these shortages by the end of the year, according to an Oct. 17 news release from the company.

It may be mid- to late-November before IV fluid products from Baxter International Inc.’s Marion plant make their way back into the marketplace. The North Cove plant experienced significant ...

28 issued a Special Bulletin to members informing them of the Food and Drug Administration's authorization extending the use date for certain Baxter products amid the ongoing IV solutions shortage.